CRISPR/Cas9 in Chronic Lymphocytic Leukemia

Impacto

Downloads

Downloads per month over past year

Hernández Sánchez, María (2022) CRISPR/Cas9 in Chronic Lymphocytic Leukemia. Encyclopedia, 2 (2). pp. 928-936. ISSN 2673-8392

[thumbnail of encyclopedia-02-00061.pdf]
Preview
PDF
Creative Commons Attribution.

317kB

Official URL: https://doi.org/10.3390/encyclopedia2020061




Abstract

Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies of Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification of somatic mutations in CLL models.


Item Type:Article
Uncontrolled Keywords:leukemia; CRISPR/Cas9; editing
Subjects:Medical sciences > Medicine > Oncology
Medical sciences > Biology > Genetics
Medical sciences > Pharmacy > Biochemistry
ID Code:74852
Deposited On:30 Sep 2022 12:13
Last Modified:03 Oct 2022 06:58

Origin of downloads

Repository Staff Only: item control page